SCHEMBL375314

SCHEMBL375314

CC(C)N1CC[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005195 0.89 KDM4E (0.32)
SCHEMBL1998910 0.87 CHRNA7 (0.34)
SCHEMBL738216 0.82
SCHEMBL7906919 0.81 CHRNA7 (0.37)
SCHEMBL197609 0.77
SCHEMBL13290568 0.75 CHRNA7 (0.46)
SCHEMBL13290580 0.75 CHRNA7 (0.46)
SCHEMBL13290572 0.75 CHRNA7 (0.46)
SCHEMBL681912 0.75 CHRNA7 (0.46)
SCHEMBL6660188 0.75 CHRNA7 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 798 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115611856-B Piperidine derivative and pharmaceutical composition, preparation method and application thereof 宜昌人福药业有限责任公司 2024-07-05 CN claimed
US-20240197888-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2024-06-20 US claimed
US-20240174643-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2024-05-30 US claimed
EP-4355741-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Biotheryx, Inc. (US) 2024-04-24 EP claimed
EP-4345096-A1 PIPERIDINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF Yichang Humanwell Pharmaceutical Co., Ltd. (CN) 2024-04-03 EP claimed
CN-117794923-A Benzodioxane compound, and preparation method and application thereof 南京红云生物科技有限公司 2024-03-29 CN claimed
CN-117642389-A Piperidine derivative and pharmaceutical composition, preparation method and application thereof 宜昌人福药业有限责任公司 2024-03-01 CN claimed
CN-117642402-A Spiropiperidine ring derivative and pharmaceutical composition, preparation method and application thereof 宜昌人福药业有限责任公司 2024-03-01 CN claimed
WO-2024024962-A1 NITROGEN-CONTAINING SATURATED HETEROCYCLIC RING DERIVATIVE 住友ファーマ株式会社 2024-02-01 WO claimed
US-20230310428-A1 EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-10-05 US claimed
WO-2002076986-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-03 WO claimed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO claimed
WO-2002034760-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2002-05-02 WO claimed
US-6326359-B1 PURINE DERIVATIVES PFIZER INC 2001-12-04 US claimed
EP-1140839-A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR XA ELI LILLY AND COMPANY (US) 2001-10-10 EP claimed
WO-2001060835-A1 PURINE DERIVATIVES PFIZER LIMITED (GB) 2001-08-23 WO claimed
EP-1121372-A1 ADENINE DERIVATIVES Pfizer Limited (GB) 2001-08-08 EP claimed
WO-2000039092-A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa ELI LILLY AND COMPANY (US) 2000-07-06 WO claimed
WO-2000023457-A1 ADENINE DERIVATIVES PFIZER LIMITED (GB) 2000-04-27 WO claimed
US-3931198-A CNS STIMULANTS OR DEPRESSANTS ABBOTT LABORATORIES (US) 1976-01-06 US claimed